First Time Loading...

Viatris Inc
NASDAQ:VTRS

Watchlist Manager
Viatris Inc Logo
Viatris Inc
NASDAQ:VTRS
Watchlist
Price: 11.14 USD -1.94% Market Closed
Updated: May 15, 2024

Revenue Breakdown

Breakdown by Geography
Viatris Inc

Not Available

Breakdown by Segments
Viatris Inc

Total Revenue: 15.4B USD
100%
Net Sales: 15.4B USD
99.8%
Brands: 9.8B USD
63.5%
Generics: 5.6B USD
36.2%
Lipitor ®: 1.6B USD
10.1%
Norvasc ®: 732.4m USD
4.7%
Lyrica ®: 556.5m USD
3.6%
Epipen® Auto-Injectors: 442.2m USD
2.9%
Viagra ®: 428.8m USD
2.8%
Celebrex ®: 330.6m USD
2.1%
Creon ®: 304.9m USD
2%
Effexor ®: 262.9m USD
1.7%
Zoloft ®: 235.7m USD
1.5%
Yupelri ®: 220.8m USD
1.4%
Dymista ®: 200m USD
1.3%
Xalabrands: 193.2m USD
1.3%
Influvac ®: 192.4m USD
1.2%
Amitiza ®: 157m USD
1%
Xanax ®: 154.8m USD
1%
Show More
Show Less

See Also

Discover More